0001628945-22-000161.txt : 20221013 0001628945-22-000161.hdr.sgml : 20221013 20221013200356 ACCESSION NUMBER: 0001628945-22-000161 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221011 FILED AS OF DATE: 20221013 DATE AS OF CHANGE: 20221013 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sever Clint CENTRAL INDEX KEY: 0001868945 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40824 FILM NUMBER: 221310032 MAIL ADDRESS: STREET 1: C/O CUE HEALTH INC. STREET 2: 4980 CARROLL CANYON RD. SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Health Inc. CENTRAL INDEX KEY: 0001628945 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4980 CARROLL CANYON ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 412-8151 MAIL ADDRESS: STREET 1: 4980 CARROLL CANYON ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Cue Inc. DATE OF NAME CHANGE: 20141223 FORMER COMPANY: FORMER CONFORMED NAME: Cue, Inc. DATE OF NAME CHANGE: 20141222 4 1 wf-form4_166570581024649.xml FORM 4 X0306 4 2022-10-11 0 0001628945 Cue Health Inc. HLTH 0001868945 Sever Clint C/O CUE HEALTH INC. 4980 CARROLL CANYON RD. SUITE 100 SAN DIEGO CA 92121 0 1 0 0 Chief Product Officer Common Stock 2022-10-11 4 M 0 26664 0.20 A 3976944 D Common Stock 2022-10-11 4 S 0 26664 3.32 D 3950280 D Common Stock 2022-10-12 4 M 0 26664 0.20 A 3976944 D Common Stock 2022-10-12 4 S 0 26664 3.24 D 3950280 D Common Stock 2022-10-13 4 M 0 26664 0.20 A 3976944 D Common Stock 2022-10-13 4 S 0 26664 3.30 D 3950280 D Employee Stock Option (right to buy) 0.2 2022-10-11 4 M 0 26664 0 D 2022-12-31 Common Stock 26664.0 373384 D Employee Stock Option (right to buy) 0.2 2022-10-12 4 M 0 26664 0 D 2022-12-31 Common Stock 26664.0 346720 D Employee Stock Option (right to buy) 0.2 2022-10-13 4 M 0 26664 0 D 2022-12-31 Common Stock 26664.0 320056 D The transactions reported on this Form 4 were automatically effected pursuant to a rule 10b5-1 trading plan adopted on June 6, 2022 and established by the reporting person for the purpose of an orderly sale of shares related to the exercises of options scheduled to expire on December 31, 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.205 to $3.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.16 to $3.37, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.115 to $3.43, inclusive. Shares subject to the option are fully vested and immediately exercisable. /s/ Erica Palsis, Attorney-in-Fact for Clint Sever 2022-10-13